-
公开(公告)号:US20220313795A1
公开(公告)日:2022-10-06
申请号:US17329137
申请日:2021-05-24
Inventor: Kamel Khalili , Wenhui Hu
Abstract: A method of preventing transmission of a retrovirus from a mother to her offspring, by administering to the mother a therapeutically effective amount of a composition comprising a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated endonuclease, and the two or more different multiplex gRNAs, wherein each of the at least two gRNAs is complementary to a different target nucleic acid sequence in a long terminal repeat (LTR) of proviral DNA of the virus that is unique from the genome of the host cell, cleaving a double strand of the proviral DNA at a first target protospacer sequence with the CRISPR-associated endonuclease, cleaving a double strand of the proviral DNA at a second target protospacer sequence with the CRISPR-associated endonuclease, excising an entire HIV-1 proviral genome, eradicating the HIV-1 proviral DNA from the host cell, and preventing transmission of the proviral DNA to the offspring.
-
公开(公告)号:US20210069303A1
公开(公告)日:2021-03-11
申请号:US16874295
申请日:2020-05-14
Inventor: Kamel Khalili , Wenhui Hu
Abstract: A method of preventing transmission of a retrovirus from a mother to her offspring, by administering to the mother a therapeutically effective amount of a composition comprising a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated endonuclease, and the two or more different multiplex gRNAs, wherein each of the at least two gRNAs is complementary to a different target nucleic acid sequence in a long terminal repeat (LTR) of proviral DNA of the virus that is unique from the genome of the host cell, cleaving a double strand of the proviral DNA at a first target protospacer sequence with the CRISPR-associated endonuclease, cleaving a double strand of the proviral DNA at a second target protospacer sequence with the CRISPR-associated endonuclease, excising an entire HIV-1 proviral genome, eradicating the HIV-1 proviral DNA from the host cell, and preventing transmission of the proviral DNA to the offspring.
-
公开(公告)号:US20180296649A1
公开(公告)日:2018-10-18
申请号:US15578372
申请日:2016-06-01
Inventor: Kamel Khalili , Wenhui Hu , Yonggang Zhang
Abstract: Compositions for specifically cleaving target sequences in retroviruses include nucleic acids encoding a Clustered Regularly Interspace Short Palindromic Repeat (CRISPR) associated endonuclease and a guide RNA sequence complementary to one or more target nucleic acid sequences in a retrovirus genome.
-
公开(公告)号:US09981020B2
公开(公告)日:2018-05-29
申请号:US15148261
申请日:2016-05-06
Inventor: Kamel Khalili , Wenhui Hu
IPC: A61K48/00 , A61K38/46 , A61K9/00 , A61K35/12 , A61K45/06 , C12N7/00 , C12N9/22 , C12N15/11 , A61K39/21 , C12N15/55 , C12N15/79 , C12N15/85 , C12N15/86
CPC classification number: A61K38/465 , A61K9/0034 , A61K35/12 , A61K45/06 , A61K48/00 , A61K48/005 , C12N7/00 , C12N9/22 , C12N15/111 , C12N2310/20 , C12N2320/30 , C12N2740/16063 , C12Y301/21
Abstract: A method of inactivating a proviral DNA integrated into the genome of a host cell latently infected with a retrovirus by treating the host cell with a composition comprising a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated endonuclease, and two or more different guide RNAs (gRNAs), wherein each of the at least two gRNAs is complementary to a different target nucleic acid sequence in a long terminal repeat (LTR) in the proviral DNA, and inactivating the proviral DNA. A composition for use in inactivating a proviral DNA integrated into the genome of a host cell latently infected with a retrovirus including isolated nucleic acid sequences comprising a CRISPR-associated endonuclease and a guide RNA, wherein the guide RNA is complementary to a target sequence in a human immunodeficiency virus.
-
公开(公告)号:US20180105867A1
公开(公告)日:2018-04-19
申请号:US15787319
申请日:2017-10-18
Applicant: Drexel University , The Wistar Institute of Anatomy and Biology , Temple University - of the Commonwealth System of Higher Education
Inventor: Ming Xiao , Harold C. Riethman , Wenhui Hu , Jennifer McCaffrey
CPC classification number: C12Q1/6806 , C12Y301/00 , G01N1/30 , G01N21/6428 , G01N2021/6439 , C12Q2521/301
Abstract: Provided herein are methods of detecting a target nucleic acid sequence. In one embodiment, the method includes contacting genomic DNA with a guide RNA having a portion complementary to the target sequence in the genomic DNA and with Cas9 nickase to produce a single-strand break in the genomic DNA at a specific location adjacent to the target sequence. The method further includes contacting the nicked DNA with a polymerase and fluorescently labeled nucleotide. The fluorescently labeled nucleotide is incorporated into the nicked DNA at the specific location and the target nucleic acid sequence is detected via fluorescent label.
-
公开(公告)号:US12251429B2
公开(公告)日:2025-03-18
申请号:US17017037
申请日:2020-09-10
Inventor: Kamel Khalili , Wenhui Hu , Yonggang Zhang
Abstract: Compositions for specifically cleaving target sequences in retroviruses include nucleic acids encoding a Clustered Regularly Interspace Short Palindromic Repeat (CRISPR) associated endonuclease and a guide RNA sequence complementary to one or more target nucleic acid sequences in a retrovirus genome.
-
公开(公告)号:US20250082778A1
公开(公告)日:2025-03-13
申请号:US18921813
申请日:2024-10-21
Inventor: Kamel Khalili , Wenhui Hu , Hassen Wollebo
IPC: A61K48/00 , C12N9/22 , C12N15/113 , C12N15/63
Abstract: The present invention includes methods and compositions for elimination of polyomaviruses, such as John Cunningham Virus (JVC), from host cells, and the treatment of polyomavirus related diseases, such as progressive multifocal leukoencephalopathy (PML). The compositions include isolated nucleic acid sequences comprising an CRISPR-associated endonuclease and a guide RNA, wherein the guide RNA is complementary to a target sequence in a polyomavirus.
-
公开(公告)号:US20230181698A1
公开(公告)日:2023-06-15
申请号:US17832457
申请日:2022-06-03
Inventor: Kamel Khalili , Wenhui Hu
CPC classification number: A61K38/465 , C12N15/111 , A61K48/00 , A61K9/0034 , A61K35/12 , A61K45/06 , A61K48/005 , C12N7/00 , C12N9/22 , C12N2320/30 , C12N2310/20 , C12N2740/16063 , C12Y301/21
Abstract: A method of preventing transmission of a retrovirus from a mother to her offspring, by administering to the mother a therapeutically effective amount of a composition comprising a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated endonuclease, and the two or more different multiplex gRNAs, wherein each of the at least two gRNAs is complementary to a different target nucleic acid sequence in a long terminal repeat (LTR) of proviral DNA of the virus that is unique from the genome of the host cell, cleaving a double strand of the proviral DNA at a first target protospacer sequence with the CRISPR-associated endonuclease, cleaving a double strand of the proviral DNA at a second target protospacer sequence with the CRISPR-associated endonuclease, excising an entire HIV-I proviral genome, eradicating the HIV-I proviral DNA from the host cell, and preventing transmission of the proviral DNA to the offspring.
-
公开(公告)号:US11298411B2
公开(公告)日:2022-04-12
申请号:US15884427
申请日:2018-01-31
Inventor: Kamel Khalili , Wenhui Hu
Abstract: A method of treating a subject having a retroviral infection, by administering to the subject a therapeutically effective amount of a composition comprising a vector encoding a CRISPR-associated endonuclease and at least two guide RNAs, wherein the guide RNAs are complementary to two target sequences spanning from the 5′- to 3′-LTRs of the sequence in the retrovirus, and eradicating the retroviral infection. A method of immunizing a subject at risk of retroviral infection, by administering a prophylactically effective amount of a composition comprising a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated endonuclease, and two or more different guide RNAs (gRNAs), wherein each of the at least two gRNAs is complementary to a different target nucleic acid sequence in a long terminal repeat (LTR) of proviral DNA of a retrovirus to the subject, and preventing retroviral infection in the subject.
-
公开(公告)号:US20210252114A1
公开(公告)日:2021-08-19
申请号:US17068999
申请日:2020-10-13
Inventor: Kamel Khalili , Wenhui Hu
Abstract: A method of preventing transmission of a retrovirus from a mother to her offspring, by administering to the mother a therapeutically effective amount of a composition comprising a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated endonuclease, and the two or more different multiplex gRNAs, wherein each of the at least two gRNAs is complementary to a different target nucleic acid sequence in a long terminal repeat (LTR) of proviral DNA of the virus that is unique from the genome of the host cell, cleaving a double strand of the proviral DNA at a first target protospacer sequence with the CRISPR-associated endonuclease, cleaving a double strand of the proviral DNA at a second target protospacer sequence with the CRISPR-associated endonuclease, excising an entire HIV-1 proviral genome, eradicating the HIV-1 proviral DNA from the host cell, and preventing transmission of the proviral DNA to the offspring.
-
-
-
-
-
-
-
-
-